| Home Forums |
|
|||||||
| Bone Marrow Failure Causes, treatment approaches, terminology, related diseases |
 |
|
|
Thread Tools | Search this Thread |
|
#1
Thu Mar 17, 2011, 04:31 PM
|
|||
|
|||
|
Drug Study AML
__________________
Marlene, wife to John DX w/SAA April 2002, Stable partial remission; Treated with High Dose Cytoxan, Johns Hopkins, June 2002. Final phlebotomy 11/2016. As of July 2021 HGB 12.0, WBC 4.70/ANC 3.85, Plts 110K. 
|
|
#2
Fri Mar 18, 2011, 06:34 AM
|
|||
|
|||
|
Less is more
Hi Marlene,
Very interesting report. It is obvious that we get too high doses of many drugs - Vidaza for example was given in much higher doses many years ago for AML but the patients couldn't stand that dose so they stopped giving the drug to AML patients. Thalidomide was given in high doses - up to 800 mg/day - for MDS but the patients dropped out of the studies due to adverse effects. Now 50 mg/day is standard and I take 29 mg/day (4 caps á 50 mg/day) with good effect. Kind regards Birgitta-A
|
|
#3
Fri Mar 18, 2011, 08:38 AM
|
|||
|
|||
|
I think that is true for many drugs. For many, the standard dose is too high and many would do just as well or even better on a lower dose.
Take care, Marlene
__________________
Marlene, wife to John DX w/SAA April 2002, Stable partial remission; Treated with High Dose Cytoxan, Johns Hopkins, June 2002. Final phlebotomy 11/2016. As of July 2021 HGB 12.0, WBC 4.70/ANC 3.85, Plts 110K.
|
|
| Thread Tools | Search this Thread |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Research Study Seeking Vietnam War-Era Veterans with MDS | Marrowforums | MDS | 5 | Mon Mar 27, 2017 04:27 PM |
| Drug study on GVHD prevention | Marlene | Transplants | 1 | Thu Jun 28, 2012 03:53 PM |
| What is the case FOR drug therapy?? | GaryV | Drugs and Drug Treatments | 11 | Thu Nov 4, 2010 09:37 PM |
| New drug, Ceplene, could prevent ralapse of AML | Birgitta-A | Drugs and Drug Treatments | 0 | Tue Jul 29, 2008 07:37 AM |
